Search results for "K-Healthcare"

Considering Wegovy for Weight Loss? South Korea's Drug Safety Ministry Warns It Is Not for Everyone

Considering Wegovy for Weight Loss? South Korea's Drug Safety Ministry Warns It Is Not for Everyone

South Korea’s Ministry of Food and Drug Safety issued a strong warning on July 8 against the misuse and abuse of GLP-1 class anti-obesity...
That Rainy-Day Gloom Has a Medical Name: Inside the Science of 'Weather Illness'

That Rainy-Day Gloom Has a Medical Name: Inside the Science of 'Weather Illness'

The arrival of the rainy season brings a relentless stretch of cloudy, humid days—and with it, a collective wave of people complaining of throbbing...
The 8 A.M. Miracle: How Parkside Rehabilitation Hospital Redesigns Lives After Acute Care

The 8 A.M. Miracle: How Parkside Rehabilitation Hospital Redesigns Lives After Acute Care

Every Wednesday and Friday, Parkside Rehabilitation Hospital—located near the UN Memorial Cemetery in Nam-gu,...
“I Never Speak First. I Listen First.”

“I Never Speak First. I Listen First.”

"What is the very first thing you want to say to patients and their caregivers after they finish acute-phase treatment.
Heart Attack and Stroke Survivors Face Significantly Higher Long-Term Suicide Risk, Study Finds

Heart Attack and Stroke Survivors Face Significantly Higher Long-Term Suicide Risk, Study Finds

While controlling blood pressure and cholesterol is traditionally considered the top priority after a heart attack or...
GC Biopharma to Conduct Phase 3 Clinical Trial for Two-Dose Chickenpox Vaccine in South Korea

GC Biopharma to Conduct Phase 3 Clinical Trial for Two-Dose Chickenpox Vaccine in South Korea

GC Biopharma’s chickenpox vaccine, Barycela Inj., is set to enter a Phase 3 clinical trial in South Korea to confirm...
Daewoong Pharmaceutical Secures 145.2 Billion Won MENA Export Deal for Diabetes Drug Enblo

Daewoong Pharmaceutical Secures 145.2 Billion Won MENA Export Deal for Diabetes Drug Enblo

Daewoong Pharmaceutical’s proprietary type 2 diabetes treatment, Enblo (active ingredient: enavogliflozin), is set to...
Celltrion Secures Historic FDA Interchangeability Status for Truxima

Celltrion Secures Historic FDA Interchangeability Status for Truxima

Celltrion announced on the 1st that the U.S. Food and Drug Administration has granted interchangeable status to Truxima...
Inha University Hospital Partners with Remedi to Validate Ultra-Compact, AI-Powered X-Ray Models for Frontline Care

Inha University Hospital Partners with Remedi to Validate Ultra-Compact, AI-Powered X-Ray Models for Frontline Care

Inha University Hospital has signed a memorandum of understanding with Remedi, a medical technology developer...
Healing the Scars of War: The Lasting Legacy of Korean War Medical Aid in Seoul and Busan

Healing the Scars of War: The Lasting Legacy of Korean War Medical Aid in Seoul and Busan

When North Korea, backed by the Soviet Union and China, invaded the Republic of Korea in 1950, the international...